Novel Sulfonamide Derivatives as Inhibitors of Histone Deacetylase
Authors:
Open Access
- 20 July 2005
- journal article
- research article
- Published by Wiley in Helvetica Chimica Acta
- Vol. 88 (7) , 1630-1657
Abstract
Inhibition of the enzyme histone deacetylase (HDAC) is emerging as a novel approach to the treatment of cancer. A series of novel sulfonamide derivatives were synthesized and evaluated for their ability to inhibit human HDAC. Compounds were identified which are potent enzyme inhibitors, with IC50 values in the low nanomolar range against enzyme obtained from HeLa cell extracts, and with antiproliferative effects in cell culture. Extensive characterization of the structure–activity relationships of this series identified key requirements for activity. These include the direction of the sulfonamide bond and substitution patterns on the central phenyl ring. The alkyl spacer between the aromatic head group and the sulfonamide functionality also influenced the HDAC inhibitory activity. One of these compounds, m11.1, also designated PXD101, has entered clinical trials for solid tumors and haematological malignancies.Keywords
This publication has 26 references indexed in Scilit:
- N-Hydroxy-3-phenyl-2-propenamides as Novel Inhibitors of Human Histone Deacetylase with in Vivo Antitumor Activity: Discovery of (2E)-N-Hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824)Journal of Medicinal Chemistry, 2003
- Cloning and characterization of human histone deacetylase 8FEBS Letters, 2000
- Epigenetic Regulation of Gelsolin Expression in Human Breast Cancer CellsExperimental Cell Research, 1999
- Distinct requirements for chromatin assembly in transcriptional repression by thyroid hormone receptor and histone deacetylaseThe EMBO Journal, 1998
- What's Up and Down with Histone Deacetylation and Transcription?Cell, 1997
- Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3Proceedings of the National Academy of Sciences, 1996
- A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3pScience, 1996
- Trichostatin A Induces Morphological Changes and Gelsolin Expression by Inhibiting Histone Deacetylase in Human Carcinoma Cell LinesExperimental Cell Research, 1994
- Structural specificity for biological activity of trichostatin a, a specific inhibitor of mammalian cell cycle with potent differentiation-inducing activity in friend leukemia cells.The Journal of Antibiotics, 1990
- Reversible arrest of proliferation of rat 3Y1 fibroblasts in both the G1 and G2 phases by trichostatin AExperimental Cell Research, 1988